Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,892 | -8,851 | -6,352 | -4,098 | -1,536 |
| Depreciation Amortization | 17 | 44 | 26 | 12 | 5 |
| Accounts payable and accrued liabilities | -196 | 972 | 384 | 925 | -156 |
| Other Working Capital | 49 | 3,031 | 1,739 | 2,223 | -52 |
| Other Operating Activity | 507 | 179 | 460 | -322 | 458 |
| Operating Cash Flow | $-2,515 | $-4,625 | $-3,744 | $-1,261 | $-1,280 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -65 | -114 | -21 | -16 | -2 |
| Investing Cash Flow | $-65 | $-114 | $-21 | $-16 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -69 | 208 | N/A | N/A | N/A |
| Debt Repayment | -1 | -190 | -144 | -144 | -72 |
| Common Stock Issued | N/A | 11,329 | 10,820 | 4,402 | 63 |
| Other Financing Activity | 0 | -509 | 0 | 0 | 0 |
| Financing Cash Flow | $-70 | $10,837 | $10,675 | $4,257 | $-9 |
| Beginning Cash Position | 12,375 | 6,276 | 6,262 | 6,262 | 6,262 |
| End Cash Position | 9,724 | 12,375 | 13,173 | 9,243 | 4,972 |
| Net Cash Flow | $-2,651 | $6,099 | $6,911 | $2,981 | $-1,291 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,515 | -4,625 | -3,744 | -1,261 | -1,280 |
| Capital Expenditure | -65 | -114 | -21 | -16 | -2 |
| Free Cash Flow | -2,580 | -4,739 | -3,765 | -1,277 | -1,282 |